Angelo C.
- Country
- Italy
- Department
- Ginecologia
Research Overview
- Efficacy and Safety of Elinzanetant in Treating Vasomotor Symptoms Induced by Adjuvant Endocrine Therapy in Hormone-Receptor Positive Breast Cancer Patients
- Evaluation of Menstrual Bleeding Patterns, Tolerability, and Compliance with Norgestimate and Ethinylestradiol in Italian Women Using Monophasic Oral Contraceptives
- Efficacy and Safety Evaluation of Vipoglanstat in Moderate to Severe Endometriosis-Related Pain: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 5 of 102 partner sites.
Specializations
Women's Health
This investigator specializes in female reproductive health and hormonal therapy, with particular focus on contraceptive treatments and their effects on menstrual cycle regulation.
- Hormonal contraception management
- Menstrual cycle control
- Female reproductive medicine
Their work encompasses evaluating breakthrough bleeding patterns and treatment compliance in hormonal contraceptive interventions.
Oncology
The investigator focuses on managing treatment-related symptoms in hormone receptor-positive breast cancer patients, particularly addressing side effects of cancer therapies.
- Breast cancer supportive care
- Vasomotor symptom management
- Endocrine therapy complications
Their research extends to therapeutic approaches for managing hot flashes induced by adjuvant endocrine therapy.
Therapeutic Innovation
This investigator evaluates novel therapeutic compounds, including elinzanetant for treatment-induced symptoms and advanced contraceptive formulations.
- Treatment tolerability assessment
- Patient compliance studies
- Clinical efficacy evaluation
Their work involves assessing both established and emerging treatments in women's health and oncology supportive care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.